Stay updated with breaking news from Christopher Posner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cara Therapeutics, Inc. (NASDAQ:CARA – Get Rating) shares passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $10.11 and traded as low as $4.85. Cara Therapeutics shares last traded at $4.92, with a volume of 486,751 shares. Analyst Ratings Changes Several […]
The market closed mixed, but these two companies gave investors some bad news.
24-year global pharmaceutical executive and current president and CEO of Cara Therapeutics joins KemPharm’s Board of Directors CELEBRATION, Fla., Nov. ...
24-year global pharmaceutical executive and current president and CEO of Cara Therapeutics joins KemPharm’s Board of Directors CELEBRATION, Fla., Nov. ...
24.08.2022 - Presentation will highlight opportunity for oral difelikefalin to address a significant unmet need in the treatment of pruritus in patients with NPSTAMFORD, Conn., Aug. 24, 2022 (GLOBE NEWSWIRE) - Cara Therapeutics, Inc. (Nasdaq: CARA), a ...